Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Go MakimotoDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Katsuyuki HottaCenter of Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan; ;Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan; Correspondence[email protected]

Isao OzeDivision of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan;

Kiichiro NinomiyaDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Masamoto NakanishiDepartment of Respiratory Medicine, Yamaguchi Ube Medical Center, Ube, Japan;

Naofumi HaraDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Hirohisa KanoDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Hiromi WatanabeDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Yusuke HataDepartment of Respiratory Medicine, Kure Kyosai Hospital, Kure, Japan;

Kazuya NishiiDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Takamasa NakasukaDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Junko ItanoDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Takashi NinomiyaHealth Service Center, Okayama University, Okayama, Japan;

Toshio KuboCenter for Clinical Oncology, Okayama University Hospital, Okayama, Japan;

Kadoaki OhashiDepartment of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan;

Eiki IchiharaDepartment of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan;

Daisuke MinamiDepartment of Respiratory Medicine, Okayama Medical Center, Okayama, Japan

Akiko SatoDepartment of Respiratory Medicine, Okayama Medical Center, Okayama, Japan

Masahiro TabataCenter for Clinical Oncology, Okayama University Hospital, Okayama, Japan;

Yoshinobu MaedaDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

Katsuyuki KiuraDepartment of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan;

show all

Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date